As the number of patients who receive onabotulinumtoxinA (onabotA [Botox]) injections for overactive bladder increases, so does the age of this population and their associated comorbidities. This raises the question: Is the use of onabotA in patients who are taking anticoagulant or antiplatelet medication safe?
“We noticed that if you were White and had prostate cancer and received androgen deprivation therapy, you were more likely to be diagnosed with depression…
Patients with elevated CTC count at baseline experienced poor complete response rates and worsened PFS and OS.
The WATER IV PCa will assess Aquablation vs radical prostatectomy in patients with grade group 1 to 3 localized prostate cancer.
“Aquablation is versatile. It can manage a very wide range of prostate sizes and shapes,” says Stephen Overholser, MD.
“Both AR and neuroendocrine marker expressions in mCSPC patients at baseline is associated with worse prognosis,” says Cedric Pobel, MD.
Illuccix is now indicated for use in the selection of patients with mCRPC for PSMA-targeted radionuclide therapy.
“I think it’s a really nice synergy between the 2 technologies,” says Wayne G. Brisbane, MD.
“As we expected, the MRIs with contrast were far more expensive,” says Benjamin Pockros, MD, MBA.
“Our findings suggest that high PSMA tumors may respond better to AR-targeting therapies. Tumors with low PSMA possess markers of cancer stem cells and are…
“Patient-reported satisfaction scores were high for both telehealth and inpatient visits for both new and established encounters,” says Daniel Carson, MD, MS.
